Top Biochemistry, Genetics and Molecular Biology journals
1,066 ranked journals whose recent papers are mostly in Biochemistry, Genetics and Molecular Biology, compared only with each other.
There are 1,066 ranked Biochemistry, Genetics and Molecular Biology journals. Together they published 1,329,144 papers in 2021–2025, and the median journal published 392 papers. 78% of their papers are open access, and 370 of the journals (35%) are listed in DOAJ (see the open-access Biochemistry, Genetics and Molecular Biology journals). The table shows the top 100.
Some long-established journals are still having their field re-checked on their recent papers; they join this list automatically when that check is done.
| Rank | Journal | Score | Papers 2021–2025 | h-index | 2-yr mean citedness | Open access |
|---|---|---|---|---|---|---|
| #1 | Cell Cell Press | 96.3 | 2,496 | 1,234 | 40.8 | 80% |
| #2 | Nature Communications Nature Portfolio | 93.1 | 47,557 | 753 | 17.4 | 100% |
| #3 | Nucleic Acids Research Oxford University Press | 91.1 | 6,700 | 882 | 16.4 | 100% |
| #4 | Nature Methods Nature Portfolio | 90.5 | 1,975 | 505 | 25.2 | 55% |
| #5 | Nature Reviews Molecular Cell Biology Nature Portfolio | 90.4 | 617 | 627 | 43.2 | 30% |
| #6 | Nature Reviews Microbiology Nature Portfolio | 89.5 | 767 | 496 | 34.6 | 30% |
| #7 | Nature Genetics Nature Portfolio | 89.4 | 1,705 | 790 | 18.1 | 62% |
| #8 | Proceedings of the National Academy of Sciences National Academy of Sciences | 88.1 | 20,148 | 1,178 | 8.5 | 100% |
| #9 | Molecular Cancer BioMed Central | 87.6 | 1,227 | 293 | 28.4 | 100% |
| #10 | Science Advances American Association for the Advancement of Science | 87.4 | 11,891 | 380 | 12.8 | 100% |
| #11 | Nature Biotechnology Nature Portfolio | 87.0 | 2,196 | 641 | 12.7 | 42% |
| #12 | Molecular Cell Elsevier BV | 86.8 | 2,037 | 534 | 13.8 | 75% |
| #13 | Nature Cell Biology Nature Portfolio | 86.7 | 1,225 | 486 | 17.2 | 56% |
| #14 | Nature Chemistry Nature Portfolio | 86.4 | 1,408 | 356 | 18.9 | 44% |
| #15 | Nature Protocols Nature Portfolio | 85.6 | 844 | 392 | 20.1 | 48% |
| #16 | Advanced Drug Delivery Reviews Elsevier BV | 85.0 | 1,106 | 433 | 15.2 | 47% |
| #17 | Cell stem cell Elsevier BV | 85.0 | 843 | 376 | 18.8 | 71% |
| #18 | Journal of Controlled Release Elsevier BV | 84.7 | 4,094 | 374 | 10.9 | 31% |
| #19 | Nature Reviews Genetics Nature Portfolio | 84.6 | 599 | 532 | 17.4 | 28% |
| #20 | International Journal of Molecular Sciences Multidisciplinary Digital Publishing Institute | 83.9 | 73,629 | 427 | 6.7 | 100% |
| #21 | Cell Host & Microbe Cell Press | 83.5 | 1,041 | 319 | 15.2 | 66% |
| #22 | Nature Microbiology Nature Portfolio | 83.4 | 1,389 | 231 | 16.9 | 65% |
| #23 | Analytical Chemistry American Chemical Society | 83.3 | 12,483 | 484 | 7.0 | 26% |
| #24 | Genome biology BioMed Central | 83.0 | 1,687 | 389 | 10.3 | 100% |
| #25 | Cell Reports Cell Press | 82.8 | 7,613 | 328 | 8.4 | 100% |
| #26 | Developmental Cell Elsevier BV | 82.7 | 1,284 | 359 | 11.5 | 90% |
| #27 | Microbiome BioMed Central | 82.4 | 1,351 | 236 | 14.6 | 100% |
| #28 | Redox Biology Elsevier BV | 82.4 | 2,107 | 210 | 13.8 | 100% |
| #29 | Nature Structural & Molecular Biology Nature Portfolio | 82.0 | 1,185 | 322 | 11.5 | 65% |
| #30 | The EMBO Journal Springer Nature | 82.0 | 1,554 | 566 | 8.1 | 100% |
| #31 | Cancer Letters Elsevier BV | 81.9 | 2,440 | 269 | 10.2 | 39% |
| #32 | Nature Chemical Biology Nature Portfolio | 81.5 | 1,405 | 321 | 10.2 | 44% |
| #33 | Cell Death and Disease Springer Nature | 81.4 | 5,060 | 239 | 9.1 | 100% |
| #34 | Molecular Biology and Evolution Oxford University Press | 81.3 | 1,554 | 324 | 9.6 | 100% |
| #35 | Scientific Reports Nature Portfolio | 81.2 | 151,352 | 465 | 5.0 | 100% |
| #36 | Gut Microbes Landes Bioscience | 81.1 | 1,555 | 171 | 16.4 | 100% |
| #37 | Bioinformatics Oxford University Press | 80.9 | 4,065 | 572 | 6.1 | 89% |
| #38 | Annual Review of Biochemistry Annual Reviews | 80.9 | 127 | 542 | 25.6 | 87% |
| #39 | Biomedicine & Pharmacotherapy Elsevier BV | 80.8 | 7,599 | 226 | 8.4 | 100% |
| #40 | PLoS Biology Public Library of Science | 80.5 | 2,313 | 383 | 7.3 | 100% |
| #41 | Biotechnology Advances Elsevier BV | 80.5 | 842 | 302 | 11.5 | 36% |
| #42 | Journal of Experimental & Clinical Cancer Research BioMed Central | 80.5 | 1,812 | 186 | 12.6 | 100% |
| #43 | Pharmacology & Therapeutics Elsevier BV | 80.5 | 738 | 296 | 12.5 | 44% |
| #44 | Cell Death and Differentiation Springer Nature | 80.3 | 946 | 313 | 10.5 | 99% |
| #45 | Journal of Extracellular Vesicles Taylor & Francis | 80.3 | 744 | 172 | 20.2 | 100% |
| #46 | Nature Reviews Chemistry Nature Portfolio | 80.0 | 546 | 178 | 22.7 | 23% |
| #47 | Cell Research Springer Nature | 79.9 | 748 | 274 | 12.1 | 100% |
| #48 | Nature Biomedical Engineering Nature Portfolio | 79.8 | 903 | 200 | 14.2 | 57% |
| #49 | Frontiers in Microbiology Frontiers Media | 79.7 | 20,517 | 347 | 5.5 | 100% |
| #50 | Trends in Pharmacological Sciences Elsevier BV | 79.7 | 662 | 320 | 11.2 | 57% |
| #51 | Experimental & Molecular Medicine Springer Nature | 79.7 | 1,063 | 181 | 14.3 | 100% |
| #52 | Applied Microbiology and Biotechnology Springer Science+Business Media | 79.6 | 2,615 | 332 | 6.9 | 53% |
| #53 | Genome Research Cold Spring Harbor Laboratory Press | 79.6 | 931 | 399 | 8.3 | 100% |
| #54 | Oncogene Springer Nature | 79.6 | 2,053 | 426 | 6.5 | 63% |
| #55 | The Journal of Cell Biology Rockefeller University Press | 79.5 | 1,376 | 601 | 6.4 | 96% |
| #56 | Cellular and Molecular Life Sciences Springer Nature | 79.4 | 2,271 | 331 | 7.0 | 100% |
| #57 | Cells Multidisciplinary Digital Publishing Institute | 79.2 | 14,789 | 234 | 6.4 | 100% |
| #58 | Phytomedicine Elsevier BV | 78.7 | 4,250 | 178 | 8.9 | 21% |
| #59 | Briefings in Bioinformatics Oxford University Press | 78.3 | 3,299 | 210 | 7.6 | 78% |
| #60 | Trends in Cell Biology Elsevier BV | 78.2 | 661 | 323 | 9.2 | 49% |
| #61 | Current Opinion in Biotechnology Elsevier BV | 78.2 | 811 | 290 | 9.1 | 63% |
| #62 | Trends in Biochemical Sciences Elsevier BV | 78.1 | 671 | 398 | 8.2 | 56% |
| #63 | Trends in biotechnology Elsevier BV | 78.1 | 963 | 313 | 8.1 | 43% |
| #64 | The American Journal of Human Genetics Elsevier BV | 78.1 | 1,059 | 390 | 7.0 | 95% |
| #65 | FEMS Microbiology Reviews Oxford University Press | 77.9 | 281 | 318 | 14.2 | 88% |
| #66 | Molecular Therapy Elsevier BV | 77.8 | 1,941 | 260 | 7.0 | 98% |
| #67 | Marine Drugs Multidisciplinary Digital Publishing Institute | 77.7 | 3,218 | 213 | 7.1 | 100% |
| #68 | Plant Biotechnology Journal Wiley | 77.7 | 1,663 | 202 | 8.5 | 100% |
| #69 | Seminars in Cancer Biology Elsevier BV | 77.7 | 696 | 228 | 10.7 | 39% |
| #70 | International Journal of Biological Sciences Ivyspring International Publisher | 77.7 | 1,856 | 166 | 10.0 | 100% |
| #71 | Trends in Microbiology Elsevier BV | 77.5 | 854 | 291 | 8.2 | 46% |
| #72 | mBio American Society for Microbiology | 77.4 | 4,076 | 228 | 6.4 | 100% |
| #73 | Archives of Toxicology Springer Science+Business Media | 77.1 | 1,298 | 183 | 9.3 | 61% |
| #74 | Biomolecules Multidisciplinary Digital Publishing Institute | 77.0 | 9,071 | 191 | 6.3 | 100% |
| #75 | Current Opinion in Structural Biology Elsevier BV | 77.0 | 863 | 253 | 8.3 | 67% |
| #76 | Scientific Data Nature Portfolio | 76.9 | 5,707 | 215 | 6.1 | 100% |
| #77 | Journal of Molecular Biology Elsevier BV | 76.7 | 2,025 | 487 | 4.8 | 62% |
| #78 | Trends in Genetics Elsevier BV | 76.6 | 702 | 330 | 7.5 | 55% |
| #79 | Genome Medicine BioMed Central | 76.5 | 773 | 180 | 10.9 | 100% |
| #80 | Nature Reviews Methods Primers Nature Portfolio | 76.4 | 451 | 110 | 28.7 | 36% |
| #81 | Cell Communication and Signaling BioMed Central | 76.1 | 1,919 | 134 | 10.2 | 100% |
| #82 | Natural Product Reports Royal Society of Chemistry | 75.9 | 605 | 250 | 8.6 | 52% |
| #83 | Cancer and Metastasis Reviews Springer Science+Business Media | 75.8 | 364 | 216 | 12.1 | 67% |
| #84 | Applied and Environmental Microbiology American Society for Microbiology | 75.7 | 2,833 | 480 | 4.3 | 100% |
| #85 | Genetics Oxford University Press | 75.6 | 1,178 | 423 | 5.2 | 93% |
| #86 | International Journal of Oncology Spandidos Publishing | 75.5 | 678 | 153 | 12.4 | 99% |
| #87 | Journal of Advanced Research Elsevier BV | 75.5 | 1,841 | 141 | 8.9 | 100% |
| #88 | Nature Aging Nature Portfolio | 75.2 | 1,033 | 103 | 16.6 | 52% |
| #89 | Cell Death Discovery Springer Nature | 75.1 | 2,513 | 108 | 10.9 | 100% |
| #90 | Microbiology and Molecular Biology Reviews American Society for Microbiology | 75.1 | 199 | 316 | 11.7 | 99% |
| #91 | BMC Bioinformatics BioMed Central | 74.9 | 2,438 | 315 | 4.7 | 100% |
| #92 | Aging Cell Wiley | 74.8 | 1,626 | 220 | 6.1 | 100% |
| #93 | EMBO Reports Springer Nature | 74.8 | 1,631 | 252 | 5.7 | 100% |
| #94 | Current Opinion in Cell Biology Elsevier BV | 74.8 | 544 | 333 | 6.9 | 66% |
| #95 | Biochimica et Biophysica Acta (BBA) - Reviews on Cancer Elsevier BV | 74.8 | 880 | 209 | 7.4 | 35% |
| #96 | Cold Spring Harbor Perspectives in Biology Cold Spring Harbor Laboratory Press | 74.8 | 354 | 304 | 8.5 | 89% |
| #97 | Annual Review of Pathology Mechanisms of Disease Annual Reviews | 74.6 | 117 | 184 | 23.9 | 90% |
| #98 | Communications Biology Nature Portfolio | 74.6 | 7,878 | 147 | 6.3 | 100% |
| #99 | Microbial Cell Factories BioMed Central | 74.6 | 1,414 | 167 | 7.6 | 100% |
| #100 | Antibiotics Multidisciplinary Digital Publishing Institute | 74.3 | 7,688 | 150 | 6.2 | 100% |
Other journal rankings
Looking for a journal for your paper? Use the journal finder.
How the ITS Journal Score works
One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.
A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.
What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.